Albemarle Corp (ALB)
ALB (NYSE:Chemicals)
$66.32
-1.02
-1.51%
Today's Range: 66.00 - 67.21 |
ALB Avg Daily Volume: 737,200
| Last Update: 05/20/13 - 4:00 PM EDT |
| Volume: 887,602 |
| YTD Performance: 8.40%
|
| Open: $67.19 |
| Previous Close: $67.34 |
| 52 Week Range: $50.88 -
$67.75 |
| Oustanding Shares: 87,844,521 |
| Market Cap: 5,821,456,407 |
6-Month Chart
TheStreet Ratings Grade for ALB
| Buy |
Hold
|
Sell
|
| A+ |
A |
A- |
B+ |
B |
B- |
C+ |
C |
C- |
D+ |
D |
D- |
E+ |
E |
E- |
F |
Analysts Ratings
| Historical Rec |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
| Strong Buy |
4 |
5 |
5 |
5 |
| Moderate Buy |
1 |
1 |
1 |
1 |
| Hold |
9 |
9 |
9 |
9 |
| Moderate Sell |
0 |
0 |
0 |
0 |
| Strong Sell |
0 |
0 |
0 |
0 |
| Mean Rec. |
2.36 |
2.27 |
2.27 |
2.27 |
| Latest Dividend: |
0.24 |
| Latest Dividend Yield: |
1.45% |
| Dividend Ex-Date: |
06/12/13 |
| Price Earnings Ratio: |
21.11 |
|
| Price Earnings Comparisons: |
| ALB |
Sector Avg. |
S&P 500 |
| 21.11 |
20.60 |
17.70 |
| Price Performance History (%Change): |
| 3 Mo |
1 Yr |
3 Y |
|
2.93%
|
12.27%
|
61.45%
|
|
| GROWTH |
12 Mo |
3 Yr |
CAGR |
| Revenue |
-4.30 |
0.37 |
0.11 |
| Net Income |
-24.30 |
0.85 |
0.23 |
| EPS |
-27.30 |
0.79 |
0.21 |
| Earnings for ALB: |
| EBITDA |
0.62B |
| Revenue |
2.75B |
|
Average Earnings Estimates
;Qtr (09/13);FY (12/13);FY (12/14)&HEADING_LIST1=Qtr (06/12);Qtr (09/12);FY (12/12);FY (12/13)) |
|
| Average Estimate |
$1.04 |
$1.36 |
$4.78 |
$5.55 |
| Number of Analysts |
13 |
12 |
15 |
13 |
| High Estimate |
$1.28 |
$1.49 |
$5.11 |
$5.96 |
| Low Estimate |
$0.92 |
$1.20 |
$4.60 |
$5.25 |
| Prior Year |
$1.24 |
$1.10 |
$4.85 |
$4.78 |
| Growth Rate (Year over Year) |
-16.25% |
23.79% |
-1.51% |
16.16% |
Apr 01, 2013 | 8:39 AM EDT
ALB earnings estimates through 2014 were reduced based on cautious margin assumptions and slower sales growth, said Jefferies. Price ta...
Jan 24, 2013 | 8:08 AM EST
ALB was downgraded to Neutral from Buy, Citigroup said. $71 price target. Weaker bromine trends.
Jan 24, 2013 | 8:00 AM EST
ALB was downgraded from Buy to Hold, Deutsche Bank said. $70 price target. Company lacks near-term catalysts.
Jan 24, 2013 | 7:55 AM EST
ALB was downgraded from Overweight to Neutral, JP Morgan said. Valuation call, based on a $67 price target.
Dec 13, 2012 | 6:54 AM EST
ALB was initiated with an Outperform rating, Robert Baird said. $72 price target. Company has a solid balance sheet and is expanding pr...
Dec 03, 2012 | 8:33 AM EST
Shares of ALB now seen reaching $77, Jefferies said. Improvements in end markets. Buy rating.
Nov 13, 2012 | 7:55 AM EST
ALB was upgraded to Buy, Goldman Sachs said. Valuation call, as the stock is already pricing in lower near-term growth.
| Sep 27, 2012 | 7:30 AM EDT
These stocks are all based in some of the reddest states in the country.
Sep 18, 2012 | 8:15 AM EDT
ALB was initiated with an Equal-weight rating, Morgan Stanley said. More upside potential in other chemical "Big Ideas."
Aug 17, 2012 | 8:17 AM EDT
Shares of ALB now seen reaching $74, Jefferies said. Estimates also lowered on electronics caution. Buy rating.
